emerging diseases
DESCRIPTION
Emerging Diseases. Emerging Infectious Disease Categories (NIAID) 1 of 3. Category A Priority Pathogens Category A pathogens are those organisms/biological agents that pose the highest risk to national security and public health because they: - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/1.jpg)
Emerging Diseases
![Page 2: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/2.jpg)
Emerging Infectious Disease Categories (NIAID) 1 of 3
Category A Priority Pathogens
Category A pathogens are those organisms/biological agents that pose the highest risk to national security and public health because they:Can be easily disseminated or transmitted from person to personResult in high mortality rates and have the potential for major public health impactMight cause public panic and social disruptionRequire special action for public health preparedness
![Page 3: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/3.jpg)
Emerging Infectious Disease Categories (NIAID) 2 of 3
Category B Priority Pathogens
Category B pathogens are the second highest priority organisms/biological agents. They:Are moderately easy to disseminateResult in moderate morbidity rates and low mortality ratesRequire specific enhancements for diagnostic capacity and enhanced disease surveillance
![Page 4: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/4.jpg)
Emerging Infectious Disease Categories (NIAID) 3 of 3
Category C Priority Pathogens
Category C pathogens are the third highest priority and include emerging pathogens that could be engineered for mass dissemination in the future because ofAvailabilityEase of production and disseminationPotential for high morbidity and mortality rates and major health impact
![Page 5: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/5.jpg)
Relative risk of Emergence of New Pathogens
Hot Spots: global distribution of relative risk of an EID event caused by zoonotic pathogens from wildlife, (Jones Nature, 2008).
![Page 6: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/6.jpg)
JITMM, Bangkok, 12-14 December 2012
![Page 7: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/7.jpg)
Dengue
• Dengue present in more than 124 countries and territories
• Every year:– 70 to 100 million
infected persons– Estimated over 2 million
severe forms (among which 90 % are children)
– Approximately 21 000 deaths
There is no specific treatment and the care of the disease is based on symptomatic treatmentPreventing and managing dengue is a Public Health priority!
![Page 8: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/8.jpg)
http://www.who.int/csr/disease/dengue/impact/en/
![Page 9: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/9.jpg)
http://www.who.int/csr/disease/dengue/impact/en/
![Page 10: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/10.jpg)
Transmission of DengueMosquitoesAedes aebyptiAedes albopictus
OtherBloodTransplacental
Incubation: 8-12 days in mosquito
![Page 11: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/11.jpg)
Dengue CharacteristicsTypesDENU1, DENU2, DENU3, DENU4
Clinical OutcomesIncubation period (post-bite), 4-10 daysAsymptomatic to mild disease – majority“Break bone” feverVomiting, headachHemorrhagic fever – severe, high cas fatality
TreatmentSupportive; e.g., acetaminophen – No ASAPlatelet replacement (hemorrhagic fever)
![Page 12: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/12.jpg)
http://www.who.int/mediacentre/factsheets/fs117/en/
![Page 13: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/13.jpg)
Also a food-borne disease
• Bats (?)
![Page 14: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/14.jpg)
0
20000
40000
60000
80000
100000
120000
3/16
3/19
3/22
3/25
3/28
3/31 4/
3
4/6
4/9
4/12
4/15
4/18
4/21
4/24
4/27
4/30 5/
3
5/6
5/9
5/12
5/15
5/18
5/21
5/24
5/27
5/30 6/
2
6/5
6/8
6/11
6/14
6/17
Num
ber o
f pas
seng
er
WHO travel recommendations removed
36 11636 116
WHO travel recommendations2 April
14 67013 May
102 165102 165
25 May27 March 23 JuneScreening of exit passengers
SARS: an unknown coronavirus
• 8098 cases/ 774 deaths• 26 countries affected• trends in airline passenger
movement drop• Tourism dropped 40%• Economic loss: US$ 60 billion
SARS; the First Pandemic of 21st Century Changed the World...
JITMM, Bangkok, 12-14 December 2012
![Page 15: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/15.jpg)
Clinical Characteristics of SARSHigh feverHeadacheDiarrhea (10-20%)PneumoniaCase fatality 774/8098 (10%)Treatment – supportive care
![Page 16: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/16.jpg)
Sudden Acute Respiratory Syndrome (SARS)
Emerged in 2003 – hotel in Hong KongRapid spread worldwide – 8098 persons within 3-4
monthsLast case in 2004Person-to-person respiratory spread – dropletsSource – wet markets (live animals)Reservoir – ferretsAgent – corona virus
![Page 17: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/17.jpg)
Can entry screening delay local transmission?
Entry screening did not substantially delay local transmission ; should be balanced against the cost of implementing these measures
![Page 18: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/18.jpg)
GONORRHEA (N. gonorrheae)
#2 infectious disease in the U.S. – 600,000 cases/yr (2012)
Drug resistance:Penicillin – 1940sTetracycline – 1980sFluoroquinolones – 2007Cephalosporens - 2014
Next?
![Page 19: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/19.jpg)
Gonorrhea
Bolan GA, et al. The emerging threat of untreatable gonoccal infection. NEJM 366:486, 2012.
![Page 20: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/20.jpg)
![Page 21: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/21.jpg)
Human Avian Influenza A/H5N1 Cases by Date
and Country ( 2 October 2007)
0
5
10
15
20
25
30
Dec Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep Oct
Nov
Dec Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep Oct
Nov
Dec Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep Oct
Nov
Dec Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep Oct
No
. of c
ase
s
Vietnam (N=100) Thailand (N=25) Cambodia (N=7)Indonesia (N=107) China (N=25) Azerbaijan (N=8)Egypt (N=38) Turkey (N=12) Iraq (N=3)Nigeria (N=1) Djibouti (N=1) Lao People's Democratic Republic (N=2)
As of 2 October 2007, total of 329 cases and 201 deaths, from 12 countries, were reported.
2003 2004 2005 2006 2007
![Page 22: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/22.jpg)
![Page 23: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/23.jpg)
EPIDEMIOLOGY AND BIOLOGY OF H5N1
INFLUENZA
![Page 24: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/24.jpg)
Characteristics of H5N1Avian Influenza
1.Highly infectious and pathogenic for domestic poultry
2.Wild fowl, ducks asymptomatic reservoir
3.Now endemic in poultry in Southeast Asia
4.Proportion of humans with subclinical infection unknown
5.Case fatality in humans is >50%
![Page 25: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/25.jpg)
Spread of HSpread of H55NN11 Avian Influenza Avian Influenza
12 14 16 18 20 22 24 26 28 30 1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 2
December, 2003 January Feb 2005-6 2006-7 2004
Sou
th K
ore
a
Vie
tna
mJa
pa
n
Th
ailan
dC
am
bod
ia
Ch
ina &
Laos
Ind
on
esi
aR
esu
rgen
ce in
Th
ailan
d,
Vie
tnam
, C
am
bod
ia a
nd
In
don
esia
Eu
rop
e,
Afr
ica
![Page 26: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/26.jpg)
A New Global Concern…
Acknowledgment: Mike Perdue
![Page 27: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/27.jpg)
Intervention Strategies Intervention Strategies (H5N1)(H5N1)
• Culling (killing of infected flocks)
• Innovative surveillance strategies
- Identification and analysis of human to human clusters
- Characterization of strains
* Necessity for vaccine development(Science 304:968-9, 5/2004)
• Vaccination of bird handlers (vaccine being developed)
• Vaccination of commercial bird flocks
![Page 28: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/28.jpg)
Barriers to H5N1 Control• Reservoir in wild birds and ducks
• Economic impact of culling of poultry stocks
• Popularity of “wet markets” promotes transmission within poultry and to other species (e.g., pigs)
• Resistance to antivirals and vaccines
• Mistrust of rich nations
![Page 29: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/29.jpg)
Don’t get the flu vaccine!
![Page 30: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/30.jpg)
FACTORS CONTRIBUTING TO EMERGENCE OR RE-EMERGENCE
OF INFECTIOUS DISEASES (1)
• Human demographic change by which persons begin to live in previously uninhabited remote areas of the world and are exposed to new environmental sources of infectious agents, insects and animals
• Unsustainable urbanization causes breakdowns of sanitary and other public health measures in overcrowded cities (e.g., slums)
![Page 31: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/31.jpg)
FACTORS CONTRIBUTING TO EMERGENCE OR RE-EMERGENCE
OF INFECTIOUS DISEASES (2)
• Economic development and changes in the use of land, including deforestation, reforestation, and urbanization
• Global warming - climate changes cause changes in geographical distribution of agents and vectors
• Changing human behaviours, such as increased use of child-care facilities, sexual and drug use behaviours, and patterns of outdoor recreation
• Social inequality
![Page 32: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/32.jpg)
FACTORS CONTRIBUTING TO EMERGENCE OR RE-EMERGENCE
OF INFECTIOUS DISEASES (3)
• International travel and commerce that quickly transport people and goods vast distances
• Changes in food processing and handling, including foods prepared from many different individual animals and countries, and transported great distances
![Page 33: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/33.jpg)
FACTORS CONTRIBUTING TO EMERGENCE OR RE-EMERGENCE
OF INFECTIOUS DISEASES (4)• Evolution of pathogenic infectious agents by
which they may infect new hosts, produce toxins, or adapt by responding to changes in the host immunity.(e.g. influenza, HIV)
• Development of resistance by infectious agents such as Mycobacterium tuberculosis and Neisseria gonorrhoeae to chemoprophylactic or chemotherapeutic medicines.
![Page 34: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/34.jpg)
FACTORS CONTRIBUTING TO EMERGENCE OR RE-EMERGENCE
OF INFECTIOUS DISEASES (5)
• Resistance of the vectors of vector-borne infectious diseases to pesticides.
• Immunosuppression of persons due to medical treatments or new diseases that result in infectious diseases caused by agents not usually pathogenic in healthy hosts (e.g. leukemia patients)
![Page 35: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/35.jpg)
FACTORS CONTRIBUTING TO EMERGENCE OR RE-EMERGENCE
OF INFECTIOUS DISEASES (6)
• Deterioration in surveillance systems for infectious diseases, including laboratory support, to detect new or emerging disease problems at an early stage (e.g. Indonesian resistance to “scientific colonialism”)
• Illiteracy limits knowledge and implementation of prevention strategies
• Lack of political will – corruption, other priorities
![Page 36: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/36.jpg)
FACTORS CONTRIBUTING TO EMERGENCE OR RE-EMERGENCE
OF INFECTIOUS DISEASES (7)• Biowarfare/bioterrorism: An unfortunate
potential source of new or emerging disease threats (e.g. anthrax and letters)
• War, civil unrest – creates refugees, food and housing shortages, increased density of living, etc.
• Famine causing reduced immune capacity, etc.
• Manufacturing strategies; e.g., pooling of plasma, etc.
![Page 37: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/37.jpg)
STRATEGIES TO REDUCE THREATS (1)
• DEVELOP POLITICAL WILL AND FUNDING
• IMPROVE GLOBAL EARLY RESPONSE CAPACITY– WHO– National Disease Control Units (e.g. USCDC,
CCDC)– Training programs
![Page 38: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/38.jpg)
STRATEGIES TO REDUCE THREATS (2)
• IMPROVE GLOBAL SURVEILLANCE– Improve diagnostic capacity (training, regulations)
– Improve communication systems (web, e-mail etc.) and sharing of surveillance data
– Rapid data analysis
– Develop innovative surveillance and analysis strategies
![Page 39: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/39.jpg)
STRATEGIES TO REDUCE THREATS (3)
• IMPROVE GLOBAL SURVEILLANCE (continued)– Utilize geographical information systems
– Utilize global positioning systems
– Utilize the Global Atlas of Infectious Diseases (WHO)
– Increase and improve laboratory capacity
– Coordinate human and animal surveillance
![Page 40: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/40.jpg)
![Page 41: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/41.jpg)
STRATEGIES TO REDUCE THREATS (4)
• USE OF VACCINES– Increase coverage and acceptability (e.g.,
oral)– New strategies for delivery (e.g., nasal spray
administration)– Develop new vaccines– Decrease cost– Decrease dependency on “cold chain”
• NEW DRUG DEVELOPMENT
![Page 42: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/42.jpg)
STRATEGIES TO REDUCE THREATS (5)• DECREASE INAPPROPRIATE DRUG USE
– Improve education of clinicians and public– Decrease antimicrobial use in agriculture and food
production
• IMPROVE VECTOR AND ZOONOTIC CONTROL– Develop new safe insecticides– Develop more non-chemical strategies e.g. organic
strategies
• BETTER AND MORE WIDESPREAD HEALTH EDUCATION (e.g., west Nile virus; bed nets, mosquito repellent)
![Page 43: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/43.jpg)
STRATEGIES TO REDUCE THREATS (6)• DEVELOPMENT OF PREDICTIVE MODELS BASED ON:– Epidemiologic data
– Climate change surveillance
– Human behavior
• ESTABLISH PRIORITIES
– The risk of disease
– The magnitude of disease burden
• Morbidity/disability
• Mortality
• Economic cost
– REDUCE POTENTIAL FOR RAPID SPREAD
– DEVELOP MORE FEASIBLE CONTROL STRATEGIES
![Page 44: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/44.jpg)
Ford TE et al. Using satellite images of environmental changes to predict infectious disease outbreaks. Emerging Infect Dis 15(9):1345, 2009.
![Page 45: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/45.jpg)
STRATEGIES TO REDUCE THREATS (7)
• Develop new strategies requiring low-cost technology
• Social and political mobilization of communities
• Greater support for research
• Reduce poverty and inequality
![Page 46: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/46.jpg)
BASIC ELEMENTS IN PREPAREDNESS
• International Health Regulations• International -- WHO
– Global Outbreak Alert and Response Network (GOARN)
• 120 technical institutions participating• 2000-02 -- Responded to 34 events in 26
countries• Coordination of SARS and H5N1 threats
– Global Public Health Information Network (GPHIN)
![Page 47: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/47.jpg)
Daily Flow of GPHIN Information
scanning global news
filtering & sorting process
800-1000 articles
selected daily
12
3review for relevancy
Mon-Fri7am-5pm EST
(Hours are extended during a public health
crisis)
Ongoing 24/7
![Page 48: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/48.jpg)
LA Times, 28 Aug 2012
![Page 49: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/49.jpg)
ESSENTIAL FACTORS FOR DISEASE ERADICATION
• Knowledge of its epidemiology and transmission patterns/mode
• Availability of effective tools for diagnosis, treatment and prevention
• Knowledge of local cultural and political characteristics
• Community acceptance and mobilization• Political will and leadership• Adequate and sustained funding
![Page 50: Emerging Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062304/568135d5550346895d9d41fc/html5/thumbnails/50.jpg)
ROLE OF THE PUBLIC HEALTH PROFESSIONAL
• Establish surveillance for: – Unusual diseases– Drug resistant agents
• Assure laboratory capacity to investigate new agents (e.g., high-throughput labs)
• Develop plans for handling outbreaks of unknown agents
• Inform physicians about responsible antimicrobial use